Author : faustina-dinatale | Published Date : 2025-06-27
Description: Lupin to Face Setback with Halt on Mirabegron Launch Institutional Equities Healthcare Astellas vs Lupin and Zydus in the Myrbetriq Legal Battle Astellas Pharma is the innovator of Myrbetriq, a treatment for overactive bladder, launchedDownload Presentation The PPT/PDF document "" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Here is the link to download the presentation.
"Lupin to Face Setback with Halt on Mirabegron"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
